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Introduction Lithium-heparin plasma is the most commonly used sample type in many hospitals, but it has been suggested that it is not suitable for protein electrophoresis due to the presence of fibrinogen, which can potentially mask a paraprotein band or be misconstrued as one. Here we aimed to demonstrate that lithium-heparin plasma samples could be used for protein electrophoresis and paraprotein typing without or with ethanol treatment to remove the fibrinogen.
Method A lithium-heparin sample from a patient with IgGl, IgGk, IgAl and IgAk myeloma, a non-specific polyclonal increase and a serum control were treated with ethanol prior to protein electrophoresis. Immunofixation electrophoresis was undertaken to investigate the effect of ethanol treatment on immunoglobulin and light chains. Nephelometry was undertaken to investigate whether ethanol treatment affected the quantification of IgG levels. Densitometric evaluation of proteins after electrophoresis was used to study whether ethanol treatment affected other serum proteins. An audit was also undertaken to ascertain the magnitude of the potential interference from the fibrinogen band in heparinized samples.
Results and conclusions
Ethanol treatment significantly but incompletely removed the fibrinogen in lithium-heparin plasma samples and did not affect the integrity of any of the proteins investigated. Even without ethanol treatment, lithium-heparin plasma can be used for protein electrophoresis and paraprotein identification as the instances of interference between fibrinogen and paraproteins was low (2.3%). In rare cases where there is uncertainty or ambiguity, immunofixation electrophoresis is recommended. This report has implications in terms of reducing costs and turn-around time as it prevents the need for requesting another serum sample from patients. This may be one step towards a universal sample for all tests. 
Introduction
Lithium--heparin plasma is not ideally suited for protein electrophoresis and monoclonal protein determination due to the interference from ¢brinogen, yet it is the most commonly used sample type in many hospitals. Fibrinogen in plasma samples can be misinterpreted as a paraprotein or can potentially mask the presence of one. It has been demonstrated that ethanol precipitation can e¡ectively and selectively remove ¢brinogen from samples. 1 It was therefore our aim to determine whether lithium--heparin plasma can be used for protein electrophoresis and monoclonal protein identi¢cation, and whether ethanol treatment was e¡ective in removing ¢brinogen in the heparinized samples.
Other alternatives to ethanol have been previously proposed --such as thrombin, 2 protamine sulphate in combination with thrombin, 3 or replicase 4 --to remove the ¢brinogen interference. However, these agents are not universally available, may be relatively costly and require special preparation and storage. Furthermore, electrophoresis after treatment is more problematic because of the presence of additional proteins in the samples. Ethanol provides a simple, inexpensive and e¡ective method for reducing ¢brinogen in heparinized samples.
Di¡erent strategies exist in di¡erent hospitals regarding the screening and diagnosis of myeloma. 5 Traditionally, most have relied on serum samples on the assumption that lithium--heparin plasma can be potentially misleading due to the presence of a ¢brinogen band observed after electrophoresis. This assumption is at best a theoretical one. Here we wish to demonstrate that lithium--heparin samples can be used for protein electrophoresis to identify paraproteins.
Methods
A lithium--heparin plasma sample (Sarstedt, Leicester, UK) was obtained from known myeloma patients (IgGk, IgGl, IgAl, IgAk) and from a patient who had a non-speci¢c polyclonal increase in g-globulins; one sample was a serum control (Helena BioSciences Europe, UK). Ethical approval was granted by the local institutional ethics committee for work done as a part of method development. All samples were treated as previously described 1 with absolute ethanol at ¢nal concentrations of 40, 80, 100, 120 and 160 mL/L and made up to a ¢nal volume of 500 mL. Control samples were treated with deionized water and also made up to a ¢nal volume of 500 mL. Samples were left for 24 h at 41C to allow precipitation before electrophoresis.
Protein electrophoresis was performed using 25 mL of supernatant diluted 1:3 with deionized water on agarose gel (Helena Rep automatic electrophoresis system, Helena BioSciences Europe, UK). After staining with acid blue, followed by two 5% acetic acid washes, densitometry scanning was performed in triplicate. To qualitatively assess the e¡ect of ethanol treatment on monoclonal paraprotein identi¢cation, all samples underwent immuno¢xation electrophoresis (Beckman Coulter, USA). In addition, some samples had their IgG levels quanti¢ed in duplicate using nephelometry (Immage Immunochemistry system, Beckman Coulter, USA). Due to limited sample availability, we were unable to measure IgM and IgA levels nephelometrically. We also undertook an audit to determine the degree and potential for interference from ¢brinogen.
The e¡ect of varying concentrations of ethanol on ¢brinogen bands, albumin, g-globulins or the a 1 , a 2 and b proteins compared with untreated controls was analysed using one-way analysis of variance (ANOVA) on ranks followed by the Dunn's post hoc test (Sigma-Stat v3.0, Systat Software, UK). Statistical signi¢cance was considered if Po0.05.
Results
As shown in Figure 1 , the addition of ethanol to plasma reduced the ¢brinogen band in a concentration-dependent manner. Compared with the untreated control (A), the addition of120 mL/L of ethanol (D) signi¢cantly but incompletely removed the ¢brinogen band (polyclonal, Po0.001,9.5% decrease; IgGl, Po0.001,53% decrease; IgGk, P ¼ 0.016, 38% decrease; IgAl, Po0.001, 58% decrease), and a higher concentration of 160 mL/L was not more e¡ective (data not shown). In the case of the IgAk, we were unable to quantify the intensity of the ¢brinogen band ( Figure 1F ) due to the superimposition of the paraprotein and ¢brinogen band. However, this was resolved qualitatively on immuno¢xation (Figure1, immuno¢xation electropherograms), where the distinct monoclonal proteins are clearly seen.
Ethanol treatment did not a¡ect the qualitative detection of immunoglobulins (IgG, IgA, IgM) or the light chains (k and l) using immuno¢xation electrophoresis. Although the ¢brinogen band was faintly visible after immuno¢xation electrophoresis following ethanol treatment ( Figure 1 , lane 1, with ethanol treatment immuno¢xation electropherograms), it did not a¡ect the integrity of the immunoglobulins or light chains in the examples shown. Importantly, the results obtained were in agreement with the previously reported results obtained using the recommended serum. Nephelometric quanti¢cation showed no significant e¡ect in the IgGl patient with a mean pre-treatment IgG of 52.5 g/L and post-ethanol treatment IgG of 51.3 g/L, and in the case of IgGk the mean IgG levels were 39.4 and 42.4 g/L, respectively. Densitometric quanti¢cation showed that ethanol treatment did not signi¢cantly a¡ect albumin, g-globulins, or the a 1 , a 2 and b proteins (data not shown).
An audit of 86 protein electrophoresis analyses done in one month on lithium--heparin samples in our laboratory showed that in only two cases (2.3%) was there any ambiguity in the identi¢cation of a paraprotein ( Figure 1F ).
Discussion
Taken together, our preliminary results demonstrate that lithium--heparin samples can be used for protein electrophoresis to detect paraproteins, and that following immuno¢xation monoclonal proteins can be accurately identi¢ed. It appears that both qualitative and quantitative methods are una¡ected by ethanol treatment of lithium--heparin samples. The ¢nding that even after ethanol treatment the ¢brinogen band was not completely removed, and that it was also still present after immuno¢xation electrophoresis using anti-¢brinogen antibodies is consistent with the results of a previous study that used capillary zone electrophoresis. 6 We suggest that where there is ambiguity, immuno-¢xation should be used to con¢rm the presence of a paraprotein in the heparinized plasma samples. For example: in the IgAk myeloma case ( Figure 1F ) the ¢brinogen and paraprotein bands could not be di¡erentiated because they were superimposed. Such an example is a case in point, albeit a rarity. However, on immuno¢xation, the monoclonal proteins were easily resolved from the ¢brinogen band. Figure 1 clearly shows that with and without ethanol treatment the im-muno¢xation electropherograms were virtually identical and provided the same results as those obtained using serum samples. Thus we conclude that, while ethanol treatment reduces the ¢brinogen and does not a¡ect the integrity of the other proteins investigated, it provides no real advantage.
In our laboratory, authorizing clinical biochemists add protein electrophoresis requests to samples to presumptively rule out a monoclonal gammopathy. Our main sample type is lithium--heparin. Positive results carry a caveat stating that serum samples should be sent to con¢rm the ¢nding of a paraprotein or a polyclonal increase. Although our approach is at best a screen, we believe it would be more cost e¡ective, economical and faster to report the results found using lithium-heparin samples. Based on the audit of 86 requests in one month, only two cases were of an ambiguous nature ( Figure 1K) . A small number such as this can justify the use of the more expensive immuno¢xation electrophoresis to con¢rm or rule out a paraprotein. This has implications in terms of decreased turnaround times and less inconvenience for patients because a repeat serum sample is not required. It also ensures that patients with suspected myeloma are not lost to follow-up. Overall, this proposition will result in decreased costs for the clinical laboratory in an era where central funding is not commensurate with an increased workload.
In conclusion, lithium--heparin plasma can be used for protein electrophoresis for the detection of paraproteins and typing for monoclonal bands with or without ethanol treatment. When there is doubt, immuno¢xation electrophoresis is recommended. For laboratories that rely on plasma as their main sample type for routine analysis, this may be one step towards a universal sample for all tests.
